| Name | 4-piperazin-1-ylbenzoic acid |
|---|---|
| Synonyms |
4-(Piperazin-1-yl)benzoic acid
4-(1-Piperazinyl)benzoic acid 4-Piperazino-benzoesaeure Benzoic acid, 4-(1-piperazinyl)- MFCD03444417 4-piperazino-benzoic acid |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 424.7±30.0 °C at 760 mmHg |
| Melting Point | 295ºC |
| Molecular Formula | C11H14N2O2 |
| Molecular Weight | 206.241 |
| Flash Point | 210.6±24.6 °C |
| Exact Mass | 206.105530 |
| PSA | 52.57000 |
| LogP | 0.79 |
| Vapour Pressure | 0.0±1.1 mmHg at 25°C |
| Index of Refraction | 1.581 |
| Storage condition | 2-8°C |
| Hazard Codes | Xi: Irritant; |
|---|---|
| Risk Phrases | R36/37/38 |
| Safety Phrases | 26-36/37/39 |
| HS Code | 2933599090 |
|
~59%
85474-75-5 |
| Literature: THERAVANCE, INC. Patent: US2012/114600 A1, 2012 ; |
|
~%
85474-75-5 |
| Literature: US2012/114600 A1, ; |
|
~%
85474-75-5 |
| Literature: US2012/114600 A1, ; |
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |